“If confirmed at study completion, these results
Post# of 1418
(Total Views: 256)
Posted On: 07/16/2019 2:38:44 PM
“If confirmed at study completion, these results suggest that LymPro will be a useful adjunctive biological diagnostic test that adds confidence to a clinical AD diagnosis." -Todos incoming CMO Dr. Paula Trzepacz
https://t.co/Wp9X0r8HUR $TOMDF #Alzheimers
https://twitter.com/todosmedical/status/11511...96352?s=19
Todos expects patient enrollment to complete in an ongoing study of LymPro in the second half of 2019 and to disclose full results in a future scientific conference https://t.co/Wp9X0r8HUR $TOMDF
https://twitter.com/todosmedical/status/11511...27488?s=19
For those who want to keep up.
Also, in every PR release as of late speaking of upcoming events, things have been completed not too far after the PR.
I wonder which future scientific conference they have their sights on.
Wonder how many more weeks till Todos' uplist?
Aloha
https://t.co/Wp9X0r8HUR $TOMDF #Alzheimers
https://twitter.com/todosmedical/status/11511...96352?s=19
Todos expects patient enrollment to complete in an ongoing study of LymPro in the second half of 2019 and to disclose full results in a future scientific conference https://t.co/Wp9X0r8HUR $TOMDF
https://twitter.com/todosmedical/status/11511...27488?s=19
For those who want to keep up.
Also, in every PR release as of late speaking of upcoming events, things have been completed not too far after the PR.
I wonder which future scientific conference they have their sights on.
Wonder how many more weeks till Todos' uplist?
Aloha
(1)
(1)Todos Med Ltd. (TOMDF) Stock Research Links
Scroll down for more posts ▼